A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling

Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions

Trudy Rodgers, Malcolm Rowland · Journal of Pharmaceutical Sciences · 2006 · 919 citations

Physiologically Based Pharmacokinetics, Pharmacokinetic Modeling, Physiologically-based Pharmacokinetic Modeling +12

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery

J. Cory Kalvass, Tristan S. Maurer · Biopharmaceutics & Drug Disposition · 2002 · 413 citations

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

Dhaval K. Shah, Alison Betts · Journal of Pharmacokinetics and Pharmacodynamics · 2011 · 402 citations

Immunocytochemical Technique, Autoimmune Disease, Tissue Disposition +12

Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin

Satoshi Kitamura, Kazuya Maeda, Yi Wang et al. · Drug Metabolism and Disposition · 2008 · 352 citations

Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans

Takao Watanabe, Hiroyuki Kusuhara, Kazuya Maeda et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 348 citations